Robert E Davis - Net Worth and Insider Trading
Robert E Davis Net Worth
The estimated net worth of Robert E Davis is at least $6 Million dollars as of 2024-11-13. Robert E Davis is the SVP, Chief Scientific Officer of Intra-Cellular Therapies Inc and owns about 43,989 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $4 Million. Robert E Davis is also the Executive VP of Drug Discovery of ACADIA Pharmaceuticals Inc and owns about 105,500 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $2 Million. Details can be seen in Robert E Davis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert E Davis has not made any transactions after 2019-01-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert E Davis
Robert E Davis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert E Davis owns 2 companies in total, including Intra-Cellular Therapies Inc (ITCI) , and ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of Robert E Davis’s form 4 insider trades.
Insider Ownership Summary of Robert E Davis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2019-01-04 | SVP & Chief Scientific Officer |
| ACAD | ACADIA Pharmaceuticals Inc | 2004-05-26 | Executive VP of Drug Discovery |
Robert E Davis Latest Holdings Summary
Robert E Davis currently owns a total of 2 stocks. Among these stocks, Robert E Davis owns 43,989 shares of Intra-Cellular Therapies Inc (ITCI) as of January 4, 2019, with a value of $4 Million and a weighting of 67.28%. Robert E Davis also owns 105,500 shares of ACADIA Pharmaceuticals Inc (ACAD) as of May 26, 2004, with a value of $2 Million and a weighting of 32.72%.
Latest Holdings of Robert E Davis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2019-01-04 | 43,989 | 88.49 | 3,892,587 |
| ACAD | ACADIA Pharmaceuticals Inc | 2004-05-26 | 105,500 | 17.94 | 1,892,670 |
Holding Weightings of Robert E Davis
Robert E Davis Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert E Davis has made a total of 0 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 9,564 shares on January 4, 2019, which brought Robert E Davis around $109,603.
According to the SEC Form 4 filings, Robert E Davis has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 0 shares on May 26, 2004, which brought Robert E Davis around $0.
Insider Trading History of Robert E Davis
- 1
Robert E Davis Trading Performance
Robert E Davis Ownership Network
Ownership Network List of Robert E Davis
Ownership Network Relation of Robert E Davis
Robert E Davis Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Robert E Davis is the SVP & Chief Scientific Officer of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include director & Chairman & President & CEO Sharon Mates , EVP & Chief Commercial Officer Mark Neumann , and Chief Medical Officer Suresh K. Durgam .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Robert E Davis made no insider transaction in Intra-Cellular Therapies Inc (ITCI). Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 696,112 shares made by Sharon Mates , a net sale of 156,651 shares made by Mark Neumann , and a net sale of 105,827 shares made by Suresh K. Durgam .
In summary, during the past 3 months, insiders sold 305,712 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 305,712 shares. During the past 18 months, 1,299,251 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,299,251 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Robert E Davis Mailing Address
Above is the net worth, insider trading, and ownership report for Robert E Davis. You might contact Robert E Davis via mailing address: 3911 Sorrento Valley Boulevard, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
